首页> 外文期刊>Urology >Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome.
【24h】

Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome.

机译:前列腺包膜和保留精囊的膀胱切除术:功能改善,肿瘤预后较差。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To retrospectively evaluate the functional and oncologic results of 20 prostatic capsule and seminal vesicle-sparing cystectomies. METHODS: From June 2002 to January 2006, we performed 360 radical cystectomies, for 20 of which we used a prostatic capsule and seminal vesicle-sparing technique. Patients with Stage T1G3 bladder cancer resistant to intravesical immunotherapy or monofocal T2G3 tumors at transurethral resection of the bladder (TURB) and with preoperative normal sexual function met our inclusion criteria and underwent this procedure. Patients with involvement of the prostatic urethra or multiple tumors were excluded. Prostate-specific antigen measurement, digital rectal examination, and transrectal ultrasonography were performed preoperatively in order to avoid incidental prostate cancer findings. No patient had a preoperative prostate-specific antigen level greater than 4 ng/mL; therefore, no patient underwent preoperative prostate biopsy. The mean patient age was 57.1 years (range 39 to 66). RESULTS: Sexual function recovery and daytime and nighttime continence were reached for all patients. The local recurrence rate in our series was 20% at 2 years of follow-up. Moreover, the distant failure rate was 30%. The 1-year cancer-specific mortality rate was 10% and the 2-year rate was 20%. All disease progressions occurred in patients with Stage T2G3 tumor at TURB. CONCLUSIONS: At last follow-up, patients with Stage T1G3 tumor at TURB had not experienced disease progression. Longer follow-up and a larger cohort of patients are necessary to confirm the safety of this procedure in these patients. In our series, the local recurrence and distant metastasis rates were too high compared with those of the patients who underwent radical cystectomy without the sparing technique. Eight of ten patients with muscle invasive bladder cancer at TURB, 8 had disease progression after seminal vesicle-sparing cystectomy.
机译:目的:回顾性评估20例前列腺包囊和精囊保留性膀胱切除术的功能和肿瘤学结果。方法:从2002年6月至2006年1月,我们进行了360例根治性膀胱切除术,其中20例使用了前列腺囊和保留精囊的技术。经膀胱尿道切除术(TURB)耐受膀胱内免疫疗法或单灶性T2G3肿瘤的T1G3期膀胱癌且术前正常性功能正常的患者符合我们的纳入标准,并接受了该程序。排除患有尿道前列腺或多发肿瘤的患者。为了避免偶然发现前列腺癌,术前进行了前列腺特异性抗原测量,直肠指检和经直肠超声检查。没有患者的术前前列腺特异性抗原水平大于4 ng / mL。因此,没有患者接受术前前列腺活检。患者平均年龄为57.1岁(39至66岁)。结果:所有患者均达到性功能恢复和日夜节制。在随访的2年中,我们系列的局部复发率为20%。此外,远处的故障率为30%。一年的癌症特异性死亡率为10%,两年的死亡率为20%。所有疾病进展都发生在TURB的T2G3期肿瘤患者中。结论:在最后的随访中,TURB的T1G3期肿瘤患者未经历疾病进展。需要更长的随访时间和更大数量的患者,以确认该方法在这些患者中的安全性。在我们的系列中,与未经保留技术行根治性膀胱切除术的患者相比,局部复发和远处转移率过高。在TURB的10例肌肉浸润性膀胱癌患者中,有8例中有8例在保留精囊的膀胱切除术后疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号